+Search query
-Structure paper
Title | Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion. |
---|---|
Journal, issue, pages | Anticancer Res., Vol. 44, Page 2393-2406, Year 2024 |
Publish date | Mar 5, 2024 (structure data deposition date) |
![]() | Kawano, S. / Kawada, M.I. / Fukushima, S. / Arai, Y. / Shibata, T. / Miyano, S.W. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.79 Å |
Structure data | ![]() PDB-8yki: |
Chemicals | ![]() PDB-1ly1: ![]() ChemComp-CL: ![]() ChemComp-HOH: |
Source |
|
![]() | TRANSFERASE / FGF RECEPTOR KINASE / PROTEROS BIOSTRUCTURES GMBH |